Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
RAPTOR PHARM (NQ: RPTP)
6.540 USD  +0.140 (+2.19%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 6.340
Bid (Size) 6.530 (1800)
Ask (Size) 6.540 (2800)
Prev. Close 6.400
Today's Range 6.000 - 6.710
52wk Range 4.350 - 7.670
Shares Outstanding 55,431,651
Dividend Yield N/A
Top News
More News
Free Research Reports on CAMT, DSCO, JRCC and RPTP Issued by the Paragon Report
May 21, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
category RPTP , ACAD , MDXG , and 15 more.
from Bio-Wire.Com

More News
Read More
Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results
May 08, 2013
from GlobeNewswire News Releases
Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome
May 07, 2013
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome From French Research Institutes
May 07, 2013
from GlobeNewswire News Releases
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
category Prime Content , AEGR , REGN , and 5 more.
from Bio-Wire.Com
GSK, AZN, KERX, and RPTP Early Briefing and Review
May 02, 2013
from ACCESSWIRE
StreetInsider.com Pre-Open Movers 5/2: (YELP) (NUS) (FB) Higher; (ANSS) (SCTY) (GLUU) Lower (more...)
May 02, 2013
from StreetInsider.com News Articles
Wedbush Downgrades Raptor Pharmaceuticals (RPTP) to Neutral
May 02, 2013
from StreetInsider.com News Articles
Raptor Pharmaceutical's PROCYSBI Receives FDA Approval for the Treatment of Nephropathic Cystinosis
May 01, 2013
category Benzinga , RPTP , News , and 1 more.
from Latest Articles from Benzinga.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here